Today Pfizer offered to buy Arena Pharmaceuticals for double it’s stock price. Arena stockholders are ecstatic. Arena has products that treat thrombosis (Temanogrel) and heart muscle problems (ADP418). Blood clots and heart failure.
Pfizer intends to make money coming and going with their jab.
An Arena Pharmaceutical clinical trial, which Pfizer has proposed to take over, treats suppressed immune systems associated with MS. Their “S1P modulater” (Etrasimod) affects immunity, heart rate, smooth muscle, and endothelial barrier function.
If Pfizer acquires this company as planned, they’ll be selling products to treat many of the problems their jab creates. Arena has other products that treat thrombosis (Temanogrel) and heart muscle problems (ADP418).
Blood clots, heart failures, and immune disorders. SMH.